This is a reminder that the following Webinars is scheduled for next week:
Impact of Pharmacometric Analyses on New Drug Approval and Labeling
Decisions
March 20, 2012
1:00 - 2:00 pm EDT
Unfortunately, Dr. Lee, the original presenter and the main author of the
related article, will not be able to present at this webinar. However, I am
pleased to announce that Dr. Joga Gobburu, Professor, Executive Director,
Center for Translational Medicine, Schools of Pharmacy & Medicine,
University of Maryland, has kindly accepted to discuss the article:
Impact of pharmacometric analyses on new drug approval and labelling
decisions: a review of 198 submissions between 2000 and 2008.
Lee JY, Garnett CE, Gobburu JV, Bhattaram VA, Brar S, Earp JC, Jadhav PR,
Krudys K, Lesko LJ, Li F, Liu J, Madabushi R, Marathe A, Mehrotra N, Tornoe
C, Wang Y, Zhu H.
The purpose of the "Impact" series is to foster the use of M&S activities in
all phases of drug development by illustrating the advantages and enhancing
the applicability of M&S in product discovery, development, and marketing
programs. The series is intended for drug development project team members
from discovery to phase 4 clinical trials. This includes pharmacologists,
ADME scientists, PK/PD modelers, clinical pharmacologists, clinical
development team members, regulatory affairs specialists, and other
interested professionals.
Register for this free webinar at www.rosaandco.com/webinar
http://www.rosaandco.com/webinar . After registering you will receive a
confirmation email containing information about joining the webinar. More
information about the webinar series, an archive of past webinars, and a
list of future webinar speakers may be found at www.rosaandco.com/webinar
http://www.rosaandco.com/webinar .
Please allow 5-10 minutes for a Java applet to be installed on your computer
prior to joining our webinar series for the first time.
Toufigh Gordi, PhD
President, PK/PD and Clinical Pharmacology Services
Rosa & Co. LLC: www.rosaandco.com
E-mail: [email protected]